PATENT CLAIM ANALYSIS

Application Number: 16071263
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-06
Patent Classification: ["544", "392000"]

Abstract:
The present invention provides novel polymorphic forms of vortioxetine hydrobromide (I).

Claim (Index 7):
The crystalline Form R1 of Vortioxetine hydrobromide tert-butanol solvate according to  claim 6 , characterized by TGA as shown in  FIG. 3 .

Metadata:
- Claim Count in Document: 38.0
- Percentile: 95.0
- Lexical Diversity: 1.0
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15304929', '15048868', '15854458', '14429388', '14902326']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7897917471794702
- 35 USC 102 Novelty (BERT): 0.5434546367078373
- Combined Prediction Score: 0.7651580361323069
- Mean Citation Score: 354.065906
- Max Citation Score: 389.72733
- Similarity Product: 279.69854898126306

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test